Literature DB >> 29895980

The Anti-α4β7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation.

Quan M Nhu1,1,1, Hellen Chiao1, Fouad J Moawad1, Fei Bao1, Gauree G Konijeti1,1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29895980     DOI： 10.1038/s41395-018-0145-1

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  8 in total

Review 1.  Emerging therapies for eosinophilic esophagitis.

Authors:  Thomas Greuter; Ikuo Hirano; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2019-11-06       Impact factor: 10.793

Review 2.  Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine.

Authors:  Ian F Slack; Justin T Schwartz; Vincent A Mukkada; Shawna Hottinger; J Pablo Abonia
Journal:  Curr Allergy Asthma Rep       Date:  2020-06-06       Impact factor: 4.806

3.  British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.

Authors:  Anjan Dhar; Hasan N Haboubi; Stephen E Attwood; Marcus K H Auth; Jason M Dunn; Rami Sweis; Danielle Morris; Jenny Epstein; Marco R Novelli; Hannah Hunter; Amanda Cordell; Sharon Hall; Jamal O Hayat; Kapil Kapur; Andrew Robert Moore; Carol Read; Sarmed S Sami; Paul J Turner; Nigel J Trudgill
Journal:  Gut       Date:  2022-05-23       Impact factor: 31.793

4.  Climbing New Mountains: How Antibodies Blocking α4β7 Integrins Tamed Eosinophilic Inflammation of the Intestinal Tract.

Authors:  Courtney L Olbrich; Luke Simerly; Edwin F de Zoeten; Glenn T Furuta; Lisa A Spencer
Journal:  Dig Dis Sci       Date:  2019-08       Impact factor: 3.487

Review 5.  Critical Points on the Use of Biologicals in Allergic Diseases and Asthma.

Authors:  Ioana Agache; Catalina Cojanu; Alexandru Laculiceanu; Liliana Rogozea
Journal:  Allergy Asthma Immunol Res       Date:  2020-01       Impact factor: 5.764

Review 6.  Pathophysiology of Non-IgE-Mediated Food Allergy.

Authors:  Shouling Zhang; Scott Sicherer; M Cecilia Berin; Amanda Agyemang
Journal:  Immunotargets Ther       Date:  2021-12-29

Review 7.  Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets.

Authors:  Francesca Racca; Gaia Pellegatta; Giuseppe Cataldo; Edoardo Vespa; Elisa Carlani; Corrado Pelaia; Giovanni Paoletti; Maria Rita Messina; Emanuele Nappi; Giorgio Walter Canonica; Alessandro Repici; Enrico Heffler
Journal:  Front Physiol       Date:  2022-01-12       Impact factor: 4.566

Review 8.  Eosinophilic esophagitis. What diet? How to treat it? The point of view of a gastroenterologist working in a department of allergology.

Authors:  Andrzej Kuźmiński; Michał Przybyszewski; Justyna Przybyszewska; Zbigniew Bartuzi
Journal:  Prz Gastroenterol       Date:  2021-04-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.